BC
Bruce & Co Portfolio holdings
AUM
$323M
1-Year Est. Return
26.65%
This Fund
S&P 500
1 Year Est. Return
+26.65%
AUM
$323M
AUM Growth
+$14.5M
(+4.7%)
Holding
41
Top Sells
| 1 | +$4.26M | |
| 2 | +$2.87M | |
| 3 | +$2.43M | |
| 4 |
LVTX
LAVA Therapeutics
LVTX
|
+$689K |
| 5 |
Kodiak Sciences
KOD
|
+$377K |
Sector Composition
| 1 | Healthcare | 27.27% |
| 2 | Utilities | 24.23% |
| 3 | Industrials | 19.38% |
| 4 | Financials | 9.17% |
| 5 | Consumer Staples | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
RLI Corp
RLI
$5.72B
| $2.66M | 0.82% |
40,800
|
|
||
27
Personalis
PSNL
$793M
| $1.65M | 0.51% |
253,000
|
|
||
28
Eli Lilly
LLY
$896B
| $1.53M | 0.47% |
2,000
|
|
||
|
VG
29
Venture Global Inc
VG
$27.3B
| $1.42M | 0.44% |
100,000
|
|
||
30
SiriusXM
SIRI
$7.58B
| $1.3M | 0.4% |
55,784
|
|
||
31
Bausch Health
BHC
$2.09B
| $1.1M | 0.34% |
171,000
|
|
||
32
MannKind Corp
MNKD
$906M
| $1.05M | 0.32% |
195,073
|
|
||
|
EDAP
33
EDAP TMS
EDAP
$159M
| $1.01M | 0.31% |
438,652
-115,000
|
|
||
34
Fate Therapeutics
FATE
$167M
| $919K | 0.28% |
729,188
+300,000
|
|
||
35
Ashland
ASH
$2.75B
| $719K | 0.22% |
15,000
|
|
||
36
908 Devices
MASS
$244M
| $598K | 0.19% |
68,286
|
|
||
37
Caribou Biosciences
CRBU
$168M
| $583K | 0.18% |
250,000
|
|
||
38
Viatris
VTRS
$16.9B
| $577K | 0.18% |
58,279
|
|
||
39
WEC Energy
WEC
$38.3B
| $452K | 0.14% |
3,945
|
|
||
|
LVTX
40
DELISTED
LAVA Therapeutics
LVTX
| – | – |
-521,874
|
|